BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 2012;12:175-87. [PMID: 22369377 DOI: 10.1586/erm.11.97] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 David J, Barkema HW, Mortier R, Ghosh S, Guan le L, De Buck J. Gene expression profiling and putative biomarkers of calves 3 months after infection with Mycobacterium avium subspecies paratuberculosis. Vet Immunol Immunopathol 2014;160:107-17. [PMID: 24841487 DOI: 10.1016/j.vetimm.2014.04.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
2 Guggino G, Orlando V, Cutrera S, La Manna MP, Di Liberto D, Vanini V, Petruccioli E, Dieli F, Goletti D, Caccamo N. Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease. Immunol Lett 2015;166:87-91. [PMID: 26051682 DOI: 10.1016/j.imlet.2015.05.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ruhwald M, Andersen ES, Christensen PB, Moessner BK, Weis N. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection. PLoS One 2012;7:e45181. [PMID: 23024806 DOI: 10.1371/journal.pone.0045181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Schopfer K, Rieder HL, Bodmer T, Steinlin-Schopfer JF, Chantana Y, Studer P, Laurent D, Richner B. The sensitivity of an interferon-γ release assay in microbiologically confirmed pediatric tuberculosis. Eur J Pediatr 2014;173:331-6. [PMID: 24065457 DOI: 10.1007/s00431-013-2161-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Robison HM, Escalante P, Valera E, Erskine CL, Auvil L, Sasieta HC, Bushell C, Welge M, Bailey RC. Precision immunoprofiling to reveal diagnostic signatures for latent tuberculosis infection and reactivation risk stratification. Integr Biol (Camb) 2019;11:16-25. [PMID: 30722034 DOI: 10.1093/intbio/zyz001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Parsons SD, McGill K, Doyle MB, Goosen WJ, van Helden PD, Gormley E. Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle. PLoS One 2016;11:e0155440. [PMID: 27167122 DOI: 10.1371/journal.pone.0155440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
7 Clifford V, Zufferey C, Germano S, Ryan N, Leslie D, Street A, Denholm J, Tebruegge M, Curtis N. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays. Tuberculosis (Edinb) 2015;95:343-9. [PMID: 25837441 DOI: 10.1016/j.tube.2015.02.039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
8 Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis. Sci Rep 2019;9:18217. [PMID: 31796883 DOI: 10.1038/s41598-019-54803-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jeong YH, Hur YG, Lee H, Kim S, Cho JE, Chang J, Shin SJ, Lee H, Kang YA, Cho SN, Ha SJ. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol 2015;53:504-10. [PMID: 25428147 DOI: 10.1128/JCM.02758-14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
10 Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM. IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection. Sci Rep 2015;5:9223. [PMID: 25783975 DOI: 10.1038/srep09223] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
11 Sheridan MP, Browne JA, Doyle MB, Fitzsimons T, McGill K, Gormley E. IL-10 suppression of IFN-γ responses in tuberculin-stimulated whole blood from Mycobacterium bovis infected cattle. Vet Immunol Immunopathol 2017;189:36-42. [PMID: 28669385 DOI: 10.1016/j.vetimm.2017.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, van der Spuy GD, van Helden PD, Franken KL, Parida SK, Klein MR, Kaufmann SH, Ottenhoff TH, Walzl G. Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS One 2012;7:e38501. [PMID: 22693640 DOI: 10.1371/journal.pone.0038501] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
13 White AD, Sarfas C, Sibley LS, Gullick J, Clark S, Rayner E, Gleeson F, Català M, Nogueira I, Cardona PJ, Vilaplana C, Dennis MJ, Williams A, Sharpe SA. Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques. Pharmaceutics 2020;12:E394. [PMID: 32344890 DOI: 10.3390/pharmaceutics12050394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang S, Li Y, Shen Y, Wu J, Gao Y, Zhang S, Shao L, Jin J, Zhang Y, Zhang W. Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB. J Transl Med 2018;16:206. [PMID: 30029650 DOI: 10.1186/s12967-018-1572-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
15 Llibre A, Duffy D. Immune response biomarkers in human and veterinary research. Comp Immunol Microbiol Infect Dis 2018;59:57-62. [PMID: 30290889 DOI: 10.1016/j.cimid.2018.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Tuuminen T, Salo E, Kotilainen H, Ruhwald M. Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-up. BMJ Open 2012;2:e001751. [PMID: 23212994 DOI: 10.1136/bmjopen-2012-001751] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
17 Chiang SS, Swanson DS, Starke JR. New Diagnostics for Childhood Tuberculosis. Infect Dis Clin North Am 2015;29:477-502. [PMID: 26188605 DOI: 10.1016/j.idc.2015.05.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
18 Venturini E, Remaschi G, Berti E, Montagnani C, Galli L, de Martino M, Chiappini E. What steps do we need to take to improve diagnosis of tuberculosis in children? Expert Rev Anti Infect Ther 2015;13:907-22. [PMID: 25938981 DOI: 10.1586/14787210.2015.1040764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 Morgan J, Muskat K, Tippalagama R, Sette A, Burel J, Lindestam Arlehamn CS. Classical CD4 T cells as the cornerstone of antimycobacterial immunity. Immunol Rev 2021;301:10-29. [PMID: 33751597 DOI: 10.1111/imr.12963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tesfaye F, Sturegård E, Walles J, Winqvist N, Balcha TT, Karlson S, Mulleta D, Isberg PE, Jansson M, Björkman P. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results. Tuberculosis (Edinb) 2020;124:101984. [PMID: 32829076 DOI: 10.1016/j.tube.2020.101984] [Reference Citation Analysis]
21 Jeljeli M, Guérin-El Khourouj V, de Lauzanne A, Armand M, Chhor V, Pédron B, Dauger S, Viala J, Gressens P, Faye A, Sterkers G. Altered cytokine profiles in children with indeterminate quantiferon results and common infections. J Infect 2015;71:250-7. [PMID: 25936633 DOI: 10.1016/j.jinf.2015.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Drabe CH, Vestergaard LS, Helleberg M, Nyagonde N, Rose MV, Francis F, Theilgaard OP, Asbjørn J, Amos B, Bygbjerg IC, Ruhwald M, Ravn P. Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania. Am J Trop Med Hyg 2016;94:728-35. [PMID: 26834199 DOI: 10.4269/ajtmh.15-0633] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
23 Meier NR, Sutter TM, Jacobsen M, Ottenhoff THM, Vogt JE, Ritz N. Machine Learning Algorithms Evaluate Immune Response to Novel Mycobacterium tuberculosis Antigens for Diagnosis of Tuberculosis. Front Cell Infect Microbiol 2020;10:594030. [PMID: 33489933 DOI: 10.3389/fcimb.2020.594030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Armand M, Chhor V, de Lauzanne A, Guérin-el Khourouj V, Pédron B, Jeljeli M, Gressens P, Faye A, Sterkers G. Cytokine responses to quantiferon peptides in pediatric tuberculosis: A pilot study. Journal of Infection 2014;68:62-70. [DOI: 10.1016/j.jinf.2013.08.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
25 Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, Smith SG, Elliott AM, Dockrell HM, Katamba A. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. PLoS One 2016;11:e0146098. [PMID: 26771653 DOI: 10.1371/journal.pone.0146098] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
26 Chegou NN, Detjen AK, Thiart L, Walters E, Mandalakas AM, Hesseling AC, Walzl G. Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS One 2013;8:e64226. [PMID: 23691173 DOI: 10.1371/journal.pone.0064226] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
27 Uzorka JW, Bossink AWJ, Franken WPJ, Thijsen SFT, Leyten EMS, van Haeften AC, Doornenbal G, Boonstra P, Ottenhoff THM, Arend SM. Borderline QuantiFERON results and the distinction between specific responses and test variability. Tuberculosis (Edinb) 2018;111:102-8. [PMID: 30029893 DOI: 10.1016/j.tube.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kweon OJ, Lim YK, Kim HR, Kim TH, Lee MK. Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers. J Clin Microbiol 2019;57:e01347-19. [PMID: 31533984 DOI: 10.1128/JCM.01347-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Anterasian C, Warr AJ, Lacourse SM, Kinuthia J, Richardson BA, Nguyen FK, Matemo D, Maleche-Obimbo E, John Stewart GC, Hawn TR. Non-IFNγ Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants. Pediatr Infect Dis J 2021;40:922-9. [PMID: 34525006 DOI: 10.1097/INF.0000000000003254] [Reference Citation Analysis]
30 Schoffelen T, Self JS, Fitzpatrick KA, Netea MG, van Deuren M, Joosten LA, Kersh GJ. Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice. Diagn Microbiol Infect Dis 2015;81:234-9. [PMID: 25618420 DOI: 10.1016/j.diagmicrobio.2014.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
31 Kim SY, Koh WJ, Kim YH, Jeong BH, Park HY, Jeon K, Kim JS, Cho SN, Shin SJ. Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease. PLoS One 2014;9:e109941. [PMID: 25295870 DOI: 10.1371/journal.pone.0109941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
32 Thillai M, Pollock K, Pareek M, Lalvani A. Interferon-gamma release assays for tuberculosis: current and future applications. Expert Review of Respiratory Medicine 2013;8:67-78. [DOI: 10.1586/17476348.2014.852471] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
33 Matsushita I, Hang NTL, Hong LT, Tam DB, Lien LT, Thuong PH, Cuong VC, Hijikata M, Kobayashi N, Sakurada S, Higuchi K, Harada N, Keicho N. Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon gamma response at the time of diagnosis. International Journal of Infectious Diseases 2015;40:39-44. [DOI: 10.1016/j.ijid.2015.09.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
34 Comella-Del-Barrio P, Abellana R, Villar-Hernández R, Jean Coute MD, Sallés Mingels B, Canales Aliaga L, Narcisse M, Gautier J, Ascaso C, Latorre I, Dominguez J, Perez-Porcuna TM. A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children. Front Microbiol 2019;10:1855. [PMID: 31474956 DOI: 10.3389/fmicb.2019.01855] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Shiratori B, Leano S, Nakajima C, Chagan-Yasutan H, Niki T, Ashino Y, Suzuki Y, Telan E, Hattori T. Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients. Mediators Inflamm 2014;2014:513263. [PMID: 25378811 DOI: 10.1155/2014/513263] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
36 Sun Q, Wei W, Sha W. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation. PLoS One 2016;11:e0166501. [PMID: 28033330 DOI: 10.1371/journal.pone.0166501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
37 Qiu X, Tang Y, Zou R, Zeng Y, Yue Y, Li W, Qu Y, Mu D. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis. Sci Rep 2019;9:11408. [PMID: 31388072 DOI: 10.1038/s41598-019-47923-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Taheri M, Kouhpayeh HR, Hosseinalizadeh T, Naderi M, Bahari G, Hashemi M. A Functional Polymorphism in Promoter of the CXCL10 Gene (-135 G/A) Associated With Pulmonary Tuberculosis. Arch Clin Infect Dis 2013;8. [DOI: 10.5812/archcid.15542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Hoel IM, Jørstad MD, Marijani M, Ruhwald M, Mustafa T, Dyrhol-Riise AM. IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting. Sci Rep 2019;9:3871. [PMID: 30846768 DOI: 10.1038/s41598-019-40458-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
40 Stefanescu S, Cocoș R, Turcu-Stiolica A, Shelby ES, Matei M, Subtirelu MS, Meca AD, Stanciulescu EC, Popescu SO, Biciusca V, Pisoschi CG. Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results. Pathogens 2021;10:789. [PMID: 34206598 DOI: 10.3390/pathogens10070789] [Reference Citation Analysis]
41 Aabye MG, Latorre I, Diaz J, Maldonado J, Mialdea I, Eugen-Olsen J, Ravn P, Dominguez J, Ruhwald M. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J 2013;42:495-503. [PMID: 23349445 DOI: 10.1183/09031936.00129412] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
42 Yang Q, Cai Y, Zhao W, Wu F, Zhang M, Luo K, Zhang Y, Liu H, Zhou B, Kornfeld H, Chen X. IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment. Clin Vaccine Immunol 2014;21:1635-44. [PMID: 25274803 DOI: 10.1128/CVI.00499-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
43 Lei J, Yin X, Shang H, Jiang Y. IP-10 is highly involved in HIV infection. Cytokine 2019;115:97-103. [PMID: 30472104 DOI: 10.1016/j.cyto.2018.11.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
44 Villar-Hernández R, Latorre I, De Souza-Galvão ML, Jiménez MA, Ruiz-Manzano J, Pilarte J, García-García E, Muriel-Moreno B, Cantos A, Altet N, Millet JP, González-Díaz Y, Molina-Pinargote I, Prat C, Ruhwald M, Domínguez J. Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail. Sci Rep 2019;9:3943. [PMID: 30850687 DOI: 10.1038/s41598-019-40778-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Villar-Hernández R, Blauenfeldt T, García-García E, Muriel-Moreno B, De Souza-Galvão ML, Millet JP, Sabriá F, Sánchez-Montalvá A, Ruiz-Manzano J, Pilarte J, Jiménez MA, Centeno C, Martos C, Molina-Pinargote I, González-Díaz YD, Santiago J, Cantos A, Casas I, Guerola RM, Prat C, Andersen P, Latorre I, Ruhwald M, Domínguez J. Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination. Sci Rep 2020;10:13234. [PMID: 32764560 DOI: 10.1038/s41598-020-70204-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Hungria EM, Freitas AA, Pontes MAA, Gonçalves HS, Sousa ALOM, Costa MB, Castilho MLOR, Duthie MS, Stefani MMA. Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy. Diagnostic Microbiology and Infectious Disease 2017;87:328-34. [DOI: 10.1016/j.diagmicrobio.2017.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wang S, Diao N, Lu C, Wu J, Gao Y, Chen J, Zhou Z, Huang H, Shao L, Jin J, Weng X, Zhang Y, Zhang W. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One 2012;7:e51338. [PMID: 23272100 DOI: 10.1371/journal.pone.0051338] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
48 Dheda K, Ruhwald M, Theron G, Peter J, Yam WC. Point-of-care diagnosis of tuberculosis: Past, present and future: POC TB diagnostics review. Respirology 2013;18:217-32. [DOI: 10.1111/resp.12022] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 10.7] [Reference Citation Analysis]
49 Molina-moya B, Latorre I, Lacoma A, Prat C, Domínguez J. Recent Advances in Tuberculosis Diagnosis: IGRAs and Molecular Biology. Curr Treat Options Infect Dis 2014;6:377-91. [DOI: 10.1007/s40506-014-0034-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Jeljeli M, Guérin-El Khourouj V, Pommelet V, Hormi M, Gressens P, Faye A, Sterkers G. Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV+ and HIV- children. J Infect 2017;75:77-80. [PMID: 28478123 DOI: 10.1016/j.jinf.2017.04.009] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Wergeland I, Pullar N, Assmus J, Ueland T, Tonby K, Feruglio S, Kvale D, Damås JK, Aukrust P, Mollnes TE, Dyrhol-Riise AM. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. J Infect 2015;70:381-91. [PMID: 25597826 DOI: 10.1016/j.jinf.2014.12.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
52 Waters WR, Maggioli MF, McGill JL, Lyashchenko KP, Palmer MV. Relevance of bovine tuberculosis research to the understanding of human disease: historical perspectives, approaches, and immunologic mechanisms. Vet Immunol Immunopathol 2014;159:113-32. [PMID: 24636301 DOI: 10.1016/j.vetimm.2014.02.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
53 Aabye MG, Eugen-Olsen J, Werlinrud AM, Holm LL, Tuuminen T, Ravn P, Ruhwald M. A simple method to quantitate IP-10 in dried blood and plasma spots. PLoS One 2012;7:e39228. [PMID: 22761744 DOI: 10.1371/journal.pone.0039228] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
54 da Cunha Lisboa V, Ribeiro-Alves M, da Silva Corrêa R, Ramos Lopes I, Mafort TT, Santos AP, Porto Amadeu T, Rufino R, Silva Rodrigues L. Predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis among Other Exudative Etiologies. J Clin Microbiol 2019;58:e00927-19. [PMID: 31619524 DOI: 10.1128/JCM.00927-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
55 Ivanyi J. Function and Potentials of M. tuberculosis Epitopes. Front Immunol 2014;5:107. [PMID: 24715888 DOI: 10.3389/fimmu.2014.00107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
56 Tincati C, Cappione Iii AJ, Snyder-Cappione JE. Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma. Cells 2012;1:89-99. [PMID: 24710416 DOI: 10.3390/cells1020089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
57 Chee CB, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis: LTBI diagnosis and treatment. Respirology 2013;18:205-16. [DOI: 10.1111/resp.12002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
58 Estévez O, Anibarro L, Garet E, Pallares Á, Pena A, Villaverde C, Del Campo V, González-Fernández Á. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection. PLoS One 2020;15:e0235859. [PMID: 32687494 DOI: 10.1371/journal.pone.0235859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Latorre I, Díaz J, Mialdea I, Serra-Vidal M, Altet N, Prat C, Díez N, Escribano A, Casas I, Rodrigo C, Ausina V, Ruhwald M, Domínguez J. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children. J Infect 2014;69:590-9. [PMID: 24975172 DOI: 10.1016/j.jinf.2014.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
60 Jenum S, Dhanasekaran S, Ritz C, Macaden R, Doherty TM, Grewal HM; TB Trials Study Group. Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children. Pediatr Infect Dis J 2016;35:1336-8. [PMID: 27642776 DOI: 10.1097/INF.0000000000001328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
61 Santos VS, Goletti D, Kontogianni K, Adams ER, Molina-Moya B, Dominguez J, Crudu V, Martins-Filho PRS, Ruhwald M, Lawson L, Bimba JS, Garcia-Basteiro AL, Petrone L, Kabeer BS, Reither K, Cuevas LE. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis. Clin Microbiol Infect 2019;25:169-77. [PMID: 30076971 DOI: 10.1016/j.cmi.2018.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
62 Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, Sherwood ER. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Shock 2012;38:395-402. [PMID: 22777121 DOI: 10.1097/SHK.0b013e318265a2ab] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
63 Qiu X, Tang Y, Yue Y, Zeng Y, Li W, Qu Y, Mu D. Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis. Clin Microbiol Infect 2019;25:667-72. [PMID: 30553864 DOI: 10.1016/j.cmi.2018.12.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
64 Bates M, Zumla A. The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis. Expert Rev Mol Diagn 2016;16:307-22. [PMID: 26735769 DOI: 10.1586/14737159.2016.1139457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
65 Blauenfeldt T, Heyckendorf J, Graff Jensen S, Lange C, Drabe C, Hermansen TS, de Thurah L, Lillebaek T, Eugen-Olsen J, Seersholm N, Hoff S, Bonde J, Ruhwald M. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots. PLoS One 2014;9:e105628. [PMID: 25184553 DOI: 10.1371/journal.pone.0105628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
66 Palmer MV, Thacker TC, Rabideau MM, Jones GJ, Kanipe C, Vordermeier HM, Ray Waters W. Biomarkers of cell-mediated immunity to bovine tuberculosis. Vet Immunol Immunopathol 2020;220:109988. [PMID: 31846797 DOI: 10.1016/j.vetimm.2019.109988] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
67 Clifford V, Tebruegge M, Zufferey C, Germano S, Denholm J, Street A, Mcbryde E, Eisen D, Curtis N. Serum IP-10 in the diagnosis of latent and active tuberculosis. Journal of Infection 2015;71:696-8. [DOI: 10.1016/j.jinf.2015.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
68 Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb) 2018;111:147-53. [PMID: 30029901 DOI: 10.1016/j.tube.2018.06.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
69 Hoff ST, Salman AM, Ruhwald M, Ravn P, Brock I, Elsheikh N, Andersen P, Agger EM. Human B cells produce chemokine CXCL10 in the presence of Mycobacterium tuberculosis specific T cells. Tuberculosis (Edinb) 2015;95:40-7. [PMID: 25476870 DOI: 10.1016/j.tube.2014.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
70 Drabe CH, Blauenfeldt T, Ruhwald M. ELISA-based assay for IP-10 detection from filter paper samples. Methods Mol Biol 2014;1172:27-37. [PMID: 24908292 DOI: 10.1007/978-1-4939-0928-5_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 Bharti D, Kumar A, Mahla RS, Kumar S, Ingle H, Shankar H, Joshi B, Raut AA, Kumar H. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics 2014;66:675-81. [PMID: 25248338 DOI: 10.1007/s00251-014-0806-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
72 Wergeland I, Assmus J, Dyrhol-Riise AM. Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls. PLoS One 2016;11:e0163848. [PMID: 27685462 DOI: 10.1371/journal.pone.0163848] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
73 Buddle BM, Vordermeier HM, Hewinson RG. Experimental Infection Models of Tuberculosis in Domestic Livestock. Microbiol Spectr 2016;4. [PMID: 27726786 DOI: 10.1128/microbiolspec.TBTB2-0017-2016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
74 Whitworth HS, Scott M, Connell DW, Dongés B, Lalvani A. IGRAs – The gateway to T cell based TB diagnosis. Methods 2013;61:52-62. [DOI: 10.1016/j.ymeth.2012.12.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
75 . Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis : Conference proceedings. Vaccine 2015;33:3056-64. [DOI: 10.1016/j.vaccine.2015.03.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
76 Gupta S, Kakkar V. Recent technological advancements in tuberculosis diagnostics - A review. Biosens Bioelectron 2018;115:14-29. [PMID: 29783081 DOI: 10.1016/j.bios.2018.05.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
77 Qiu X, Xiong T, Su X, Qu Y, Ge L, Yue Y, Zeng Y, Li W, Hu P, Mu D. Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis. BMC Infect Dis 2019;19:924. [PMID: 31666025 DOI: 10.1186/s12879-019-4466-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
78 Hang NTL, Matsushita I, Shimbo T, Hong LT, Tam DB, Lien LT, Thuong PH, Cuong VC, Hijikata M, Kobayashi N, Sakurada S, Higuchi K, Harada N, Endo H, Keicho N. Association between tuberculosis recurrence and interferon-γ response during treatment. Journal of Infection 2014;69:616-26. [DOI: 10.1016/j.jinf.2014.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
79 David J, Barkema HW, Guan le L, De Buck J. Gene-expression profiling of calves 6 and 9 months after inoculation with Mycobacterium avium subspecies paratuberculosis. Vet Res 2014;45:96. [PMID: 25294045 DOI: 10.1186/s13567-014-0096-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
80 Agrawal N, Streata I, Pei G, Weiner J, Kotze L, Bandermann S, Lozza L, Walzl G, du Plessis N, Ioana M, Kaufmann SHE, Dorhoi A. Human Monocytic Suppressive Cells Promote Replication of Mycobacterium tuberculosis and Alter Stability of in vitro Generated Granulomas. Front Immunol 2018;9:2417. [PMID: 30405617 DOI: 10.3389/fimmu.2018.02417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
81 Villar-Hernández R, Latorre I, Mínguez S, Díaz J, García-García E, Muriel-Moreno B, Lacoma A, Prat C, Olivé A, Ruhwald M, Mateo L, Domínguez J. Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases. J Infect 2017;75:315-25. [PMID: 28751171 DOI: 10.1016/j.jinf.2017.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]